104 related articles for article (PubMed ID: 29386580)
21. X-linked inhibitor of apoptosis protein deficiency: more than an X-linked lymphoproliferative syndrome.
Aguilar C; Latour S
J Clin Immunol; 2015 May; 35(4):331-8. PubMed ID: 25737324
[TBL] [Abstract][Full Text] [Related]
22. IL-6 receptor blockade corrects defects of XIAP-deficient regulatory T cells.
Hsieh WC; Hsu TS; Chang YJ; Lai MZ
Nat Commun; 2018 Jan; 9(1):463. PubMed ID: 29386580
[TBL] [Abstract][Full Text] [Related]
23. Intact Regulatory T-Cell Function but Defective Generation of IL-17A-Producing CD4+ T Cells in XIAP Deficiency.
Gurram B; Hammelev E; Syverson G; Haribhai D; Yan K; Simpson P; Salzman N; Verbsky JW
J Pediatr Gastroenterol Nutr; 2016 Aug; 63(2):218-25. PubMed ID: 26825770
[TBL] [Abstract][Full Text] [Related]
24. XIAP deficiency syndrome in humans.
Latour S; Aguilar C
Semin Cell Dev Biol; 2015 Mar; 39():115-23. PubMed ID: 25666262
[TBL] [Abstract][Full Text] [Related]
25. XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome.
Rigaud S; Fondanèche MC; Lambert N; Pasquier B; Mateo V; Soulas P; Galicier L; Le Deist F; Rieux-Laucat F; Revy P; Fischer A; de Saint Basile G; Latour S
Nature; 2006 Nov; 444(7115):110-4. PubMed ID: 17080092
[TBL] [Abstract][Full Text] [Related]
26. IL-2 contributes to maintaining a balance between CD4+Foxp3+ regulatory T cells and effector CD4+ T cells required for immune control of blood-stage malaria infection.
Berretta F; St-Pierre J; Piccirillo CA; Stevenson MM
J Immunol; 2011 Apr; 186(8):4862-71. PubMed ID: 21389253
[TBL] [Abstract][Full Text] [Related]
27. SOCS1 Is a Key Molecule That Prevents Regulatory T Cell Plasticity under Inflammatory Conditions.
Takahashi R; Nakatsukasa H; Shiozawa S; Yoshimura A
J Immunol; 2017 Jul; 199(1):149-158. PubMed ID: 28550203
[TBL] [Abstract][Full Text] [Related]
28. New frontiers in the therapy of primary immunodeficiency: From gene addition to gene editing.
Kohn DB; Kuo CY
J Allergy Clin Immunol; 2017 Mar; 139(3):726-732. PubMed ID: 28270364
[TBL] [Abstract][Full Text] [Related]
29. Human Adaptive Immunity Rescues an Inborn Error of Innate Immunity.
Israel L; Wang Y; Bulek K; Della Mina E; Zhang Z; Pedergnana V; Chrabieh M; Lemmens NA; Sancho-Shimizu V; Descatoire M; Lasseau T; Israelsson E; Lorenzo L; Yun L; Belkadi A; Moran A; Weisman LE; Vandenesch F; Batteux F; Weller S; Levin M; Herberg J; Abhyankar A; Prando C; Itan Y; van Wamel WJB; Picard C; Abel L; Chaussabel D; Li X; Beutler B; Arkwright PD; Casanova JL; Puel A
Cell; 2017 Feb; 168(5):789-800.e10. PubMed ID: 28235196
[TBL] [Abstract][Full Text] [Related]
30. Adoptive T Cell Immunotherapy for Patients with Primary Immunodeficiency Disorders.
McLaughlin LP; Bollard CM; Keller M
Curr Allergy Asthma Rep; 2017 Jan; 17(1):3. PubMed ID: 28116637
[TBL] [Abstract][Full Text] [Related]
31. Antigen-specificity using chimeric antigen receptors: the future of regulatory T-cell therapy?
Boardman D; Maher J; Lechler R; Smyth L; Lombardi G
Biochem Soc Trans; 2016 Apr; 44(2):342-8. PubMed ID: 27068938
[TBL] [Abstract][Full Text] [Related]
32. Driving CAR T-cells forward.
Jackson HJ; Rafiq S; Brentjens RJ
Nat Rev Clin Oncol; 2016 Jun; 13(6):370-83. PubMed ID: 27000958
[TBL] [Abstract][Full Text] [Related]
33. Harnessing the plasticity of CD4(+) T cells to treat immune-mediated disease.
DuPage M; Bluestone JA
Nat Rev Immunol; 2016 Mar; 16(3):149-63. PubMed ID: 26875830
[TBL] [Abstract][Full Text] [Related]
34. Primary Immunodeficiencies and Inflammatory Disease: A Growing Genetic Intersection.
Fodil N; Langlais D; Gros P
Trends Immunol; 2016 Feb; 37(2):126-140. PubMed ID: 26791050
[TBL] [Abstract][Full Text] [Related]
35. Type 1 diabetes immunotherapy using polyclonal regulatory T cells.
Bluestone JA; Buckner JH; Fitch M; Gitelman SE; Gupta S; Hellerstein MK; Herold KC; Lares A; Lee MR; Li K; Liu W; Long SA; Masiello LM; Nguyen V; Putnam AL; Rieck M; Sayre PH; Tang Q
Sci Transl Med; 2015 Nov; 7(315):315ra189. PubMed ID: 26606968
[TBL] [Abstract][Full Text] [Related]
36. Primary Immunodeficiency Diseases: an Update on the Classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency 2015.
Picard C; Al-Herz W; Bousfiha A; Casanova JL; Chatila T; Conley ME; Cunningham-Rundles C; Etzioni A; Holland SM; Klein C; Nonoyama S; Ochs HD; Oksenhendler E; Puck JM; Sullivan KE; Tang ML; Franco JL; Gaspar HB
J Clin Immunol; 2015 Nov; 35(8):696-726. PubMed ID: 26482257
[TBL] [Abstract][Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
